Pollak P - Search Results

1

External and implanted pumps for apomorphine infusion in parkinsonism.

Pollak P, Benabid AL, Limousin P, Gervason CL, Jeanneau-Nicolle E. Pollak P, et al. Acta Neurochir Suppl (Wien). 1993;58:48-52. doi: 10.1007/978-3-7091-9297-9_10. Acta Neurochir Suppl (Wien). 1993. PMID: 8109301

2

Reproducibility of motor effects induced by successive subcutaneous apomorphine injections in Parkinson's disease.

Gervason CL, Pollak PR, Limousin P, Perret JE. Gervason CL, et al. Among authors: pollak pr. Clin Neuropharmacol. 1993 Apr;16(2):113-9. doi: 10.1097/00002826-199304000-00003. Clin Neuropharmacol. 1993. PMID: 8477407 Clinical Trial.

3

Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias.

Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J. Benabid AL, et al. Among authors: pollak p. Acta Neurochir Suppl (Wien). 1993;58:39-44. doi: 10.1007/978-3-7091-9297-9_8. Acta Neurochir Suppl (Wien). 1993. PMID: 8109299

4

Pharmacokinetics of apomorphine in parkinsonian patients.

Nicolle E, Pollak P, Serre-Debeauvais F, Richard P, Gervason CL, Broussolle E, Gavend M. Nicolle E, et al. Among authors: pollak p. Fundam Clin Pharmacol. 1993;7(5):245-52. doi: 10.1111/j.1472-8206.1993.tb00238.x. Fundam Clin Pharmacol. 1993. PMID: 8370571

5

Long-term electrical inhibition of deep brain targets in movement disorders.

Benabid AL, Benazzouz A, Hoffmann D, Limousin P, Krack P, Pollak P. Benabid AL, et al. Among authors: pollak p. Mov Disord. 1998;13 Suppl 3:119-25. doi: 10.1002/mds.870131321. Mov Disord. 1998. PMID: 9827607 Review.

6

Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation.

Krack P, Benazzouz A, Pollak P, Limousin P, Piallat B, Hoffmann D, Xie J, Benabid AL. Krack P, et al. Among authors: pollak p. Mov Disord. 1998 Nov;13(6):907-14. doi: 10.1002/mds.870130608. Mov Disord. 1998. PMID: 9827614

7

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.

Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid AL. Krack P, et al. Among authors: pollak p. Brain. 1999 Jun;122 ( Pt 6):1133-46. doi: 10.1093/brain/122.6.1133. Brain. 1999. PMID: 10356065

8

Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism.

Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Gentil M, et al. Among authors: pollak p. J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):329-33. doi: 10.1136/jnnp.67.3.329. J Neurol Neurosurg Psychiatry. 1999. PMID: 10449555 Free PMC article.

9

Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.

Gentil M, Tournier CL, Pollak P, Benabid AL. Gentil M, et al. Among authors: pollak p. Eur Neurol. 1999;42(3):136-40. doi: 10.1159/000008087. Eur Neurol. 1999. PMID: 10529538

10

Dyskinesias and the subthalamic nucleus.

Benabid AL, Benazzouz A, Limousin P, Koudsie A, Krack P, Piallat B, Pollak P. Benabid AL, et al. Among authors: pollak p. Ann Neurol. 2000 Apr;47(4 Suppl 1):S189-92. Ann Neurol. 2000. PMID: 10762147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters